Dr. Gerard Criner: Temple Lung Center

Temple University Hospital Network FB post:

A new investigational drug that could be a game changer in the treatment of idiopathic pulmonary fibrosis is being offered to patients at Temple Lung Center as part of a limited “expanded access” program in advance of the drug’s regulatory approval.

Learn more: http://tuh.templehealth.org/content/news.htm?inCtx4news_id=336&inCtx4view=23